Definitive Contract HR001114C0067
Award Date
3/13/14
Potential Completion Date
6/13/14
Potential Value
$124K
Federal Agency
Defense Advanced Research Projects Agency
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
AD91 - R&D- Defense Other: Other (Basic Research)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Basic Research
Number Of Offers Received
41
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Zymergen Inc. was awarded a $24.8 million other transaction agreement by the Defense Advanced Research Projects Agency to deliver on Task Area 2 of the LIVING FOUNDRIES: 1000 MOLECULES program. Under this effort, the Oakland, California-based company will leverage its synthetic biology capabilities to produce any microbe capable of manufacturing any target molecule. No set-aside designation was applied to this award. DARPA's LIVING FOUNDRIES initiative aims to develop a robust, scalable, and...
This federal contract award, valued at $31,863,305.85, is for the DARPA "Living Foundries: 1000 Molecules" program, which aims to build a scalable, integrated, rapid design and prototyping infrastructure for engineering biology. The prime contractor is the Massachusetts Institute of Technology (MIT), a premier private research university. The contract has no set-aside designation and is a definitive contract with a cost-no-fee pricing type. Major subcontractors include the Broad...
This is a $1,342,086 cost-no-fee definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to the University of Texas at Austin. The contract is part of DARPA's "Living Foundries: ATCG Program", which aims to transform biology into an engineering practice and enable the rapid development of new technologies and products leveraging biological systems. As the prime contractor, the University of Texas at Austin is leveraging its expertise in aerospace...
This is a $10,670,749 cost-plus-fixed-fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Battelle Memorial Institute, a large nonprofit research and development organization, for the TELLUS program. The TELLUS program aims to develop the methodology to program microbial sense-and-respond devices that can reliably detect various chemical and physical stimuli in DoD-relevant environments. The contract has no set-aside designation. The prime contractor, Battelle...
This is a $225,000.00 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Technology Holding LLC, a small, for-profit limited liability company specializing in research and development services. The contract is part of DARPA's Small Business Innovation Research (SBIR) program and is for Phase I of an effort titled "AUTONOMOUS BIOMANUFACTORING AT REMOTE LOCATIONS". The contract has a total small business set-aside and supports the development of...
This is a $1,509,995.97 Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Enevolv, Inc., a small business subsidiary of Zymergen Inc. The contract is for the development of "Programmable Allosteric Transcription Factors as Specific Molecular Sensor-Actuators" under DARPA's Small Business Innovation Research (SBIR) Program Phase II. The contract has a completion date of July 1, 2019 and was set aside for total small business participation.
Massachusetts Institute of Technology (MIT) has been awarded a definitive cost-no-fee contract valued at $5,914,574 by the Defense Advanced Research Projects Agency (DARPA) to conduct research in genetic circuit design for extreme environments enabled by models extracted from petabyte-scale perturbation data. Work will be performed in Cambridge, Massachusetts through March 31, 2022. No set-aside designation was used for this award issued under the agency's open market authority. MIT will serve...
This federal contract award, worth up to $21,032,097.00, was issued by the Defense Advanced Research Projects Agency (DARPA) to SRI International, a non-profit research and development organization. The contract supports DARPA's "Accelerated Molecular Discovery" (AMD) program, which aims to develop new approaches to increase the pace of discovery and optimization of high-performance molecules for Department of Defense needs. The contract does not have a set-aside designation. Under...
This is a $963,686.00 cost-plus-fixed-fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to The Charles Stark Draper Laboratory, Inc. (Draper) to pursue high-risk, high-payoff research initiatives across a broad spectrum of science and engineering disciplines. The effort aims to transform these initiatives into important, radically new, game-changing technologies for U.S. national security. The contract does not have a set-aside designation. Under this contract, Draper...
This is a $5,632,809.00 Cost Plus Fixed Fee contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Leidos, Inc. (Leidos) to develop technologies that enable immediate synthesis of bioactive protein medical countermeasures and production enzymes within 24 hours at a yield of at least 500 doses per week. The contract is part of DARPA's Reimagining Protein Manufacturing (RPM) program, which aims to establish foundational technologies for distributed, on-demand manufacturing of...